You just read:

Arena Pharmaceuticals Presented New Data Analyses Demonstrating the Long-Term Safety and Efficacy of Once-Daily Etrasimod in Patients with Moderately to Severely Active Ulcerative Colitis at UEG Week

News provided by

Arena Pharmaceuticals, Inc.

Oct 22, 2019, 16:01 ET